0001214659-23-000809.txt : 20230119
0001214659-23-000809.hdr.sgml : 20230119
20230119094536
ACCESSION NUMBER: 0001214659-23-000809
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230117
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christensen Jamie
CENTRAL INDEX KEY: 0001599324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 23536135
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS, INC.
STREET 2: 9393 TOWNE CENTRE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-58207.xml
PRIMARY DOCUMENT
X0306
4
2023-01-17
0001576263
Mirati Therapeutics, Inc.
MRTX
0001599324
Christensen Jamie
C/O MIRATI THERAPEUTICS
3545 CRAY COURT
SAN DIEGO
CA
92121
false
true
false
false
EVP, Chief Scientific Officer
Common Stock
2023-01-17
4
S
false
1358
42.3778
D
98765
D
Common Stock
2023-01-17
4
S
false
887
42.3821
D
97878
D
Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.
/s/ Reena Desai, Attorney-in-Fact
2023-01-18